US · Healthcare · Medical Devices
EPS came in at -5.37 against a street estimate of -4.69 — a miss of 14.5%.
Analysts rate enVVeno Medical Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.
| Fund | Stake |
|---|---|
| Kingdon Capital Management LLC | 5.21% |
| CM Management, LLC | 5.14% |
| Vanguard Capital Management, LLC | 0.90% |
| JPMorgan Chase & Co | 0.75% |
| Vanguard Fiduciary Trust Co | 0.31% |
| Westside Investment Management, Inc. | 0.22% |
| Mirae Asset Global Investments (Korea) Co Ltd | 0.08% |
| BlackRock Inc | 0.06% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for enVVeno Medical Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.